These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27272083)

  • 1. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
    Gold M; Dhawan S; Verma A; Kuligowski M; Dobrowski D
    J Drugs Dermatol; 2016 Jun; 15(6):743-8. PubMed ID: 27272083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
    Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
    J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
    Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B
    J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
    Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical antifungal treatments for tinea cruris and tinea corporis.
    El-Gohary M; van Zuuren EJ; Fedorowicz Z; Burgess H; Doney L; Stuart B; Moore M; Little P
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009992. PubMed ID: 25090020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis.
    Jordon RE; Rapini RP; Rex IH; Katz HI; Hickman JG; Bard JW; Medansky RS; Lew-Kaya DA; Sefton J; DeGryse RE
    Int J Dermatol; 1990; 29(6):441-2. PubMed ID: 2397973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis.
    Millikan LE; Galen WK; Gewirtzman GB; Horwitz SN; Landow RK; Nesbitt LT; Roth HL; Sefton J; Day RM
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):52-6. PubMed ID: 3279083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Naftifine HCl 2% Gel and Cream in Treating Moccasin Tinea Pedis.
    Vlahovic TC
    J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s56-9. PubMed ID: 26885800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and relevance of naftifine hydrochloride in the stratum corneum up to four weeks following the last application of naftifine cream and gel, 2%.
    Plaum S; Verma A; Fleischer AB; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Sep; 12(9):1004-8. PubMed ID: 24002147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor.
    Gold MH; Bridges T; Avakian E; Plaum S; Pappert EJ; Fleischer AB; Hardas B
    Skinmed; 2011; 9(5):283-6. PubMed ID: 22165042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group.
    J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis.
    Das A; Sil A; Sarkar TK; Sen A; Chakravorty S; Sengupta M; Das A; Chandra S; Pal S; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2019; 85(3):276-281. PubMed ID: 30409926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris.
    Bakos L; Brito AC; Castro LC; Gontijo B; Lowy G; Reis CM; Ribeiro AM; Souza FH; Villar Mdo L; Zaitz C
    Pediatr Infect Dis J; 1997 Jun; 16(6):545-8. PubMed ID: 9194102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.
    Cutis; 1991 Jul; 48(1):85-8. PubMed ID: 1868748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients.
    Sinha SD; Rajamma A; Bandi MR; Sriramadasu SC; Sahu S; Kothiwala RK; Halder S; Sankerneni A; Panapakam M; Vemireddy VNR; Vattipalli R; Devireddy SR
    Clin Drug Investig; 2023 Jul; 43(7):565-574. PubMed ID: 37462803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.